UMMC LB Building
Return to Locations Search
Address:
878 Lakeland Drive, LB Building
Jackson, MS 39216
Contact Us:
(601) 984-5770
Parking:
Free LB Building patient parking available in front of the building.
Our Providers who practice at this location:
| Provider | Specialty Keywords | ||||
|---|---|---|---|---|---|
|
Practice Locations:
|
internist, children internal medicine, childrens internal medicine, primary care, adult internal medicine, children's internal medicine, pediatric internal medicine |
Our Clinical Trials offered at this location:
Researchers at UMMC are committed to discovering innovative ways to prevent and treat the diseases that affect our daily lives. Clinical research studies play a vital role in the advancement of medicine and can improve the well-being of our families, friends, communities, and future generations. In this way, participation in clinical research studies furthers our vision to create "a healthier Mississippi."
Partnering with UMMC’s researchers may have many advantages, including:
- Gaining access to investigational treatments
- Increasing knowledge about your own health
- Giving the gift of improved health to our communities and future generations
- Contributing to the advancement of science by helping researchers learn more about how the human body and mind work or by helping find a cure or better treatments for diseases
| Clinical Trials | Publish Date | Description | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A Multicenter,Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of Brexanolone in the Treatments of Adolescent Female Subjects with Postpartum Depression.IRB Number: 2019-0255
Published: October 25, 2019
View Locations
Clinical Trial Locations:
|
20191025125433 |
<div>This study will test the effects and safety of brexanolone in adolescent female diagnosed with postpartum depression. </div><div><br></div> depression;pediatrics;women's health 547-PPD-304 Sheila Belk kwallace2 Pediatrics Women's Health |
||||||||||||
A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children (MEDLEY)IRB Number: 2019-0209
Published: November 25, 2019
View Locations
Clinical Trial Locations:
|
20191125103217 |
This study will evaluate the safety and tolerability of MEDI8897 compared to palivizumab in preterm infants entering their first RSV season and children with chronic lung disease or congenital heart disease entering their first and second RSV season. pediatrics;women's health;lungs D5290C00005 Sandra Tyler abhatt Lungs/Breathing Pediatrics Women's Health |
||||||||||||
All of Us Research ProgramIRB Number: 2018-0109
Published: November 08, 2019
View Locations
Clinical Trial Locations:
|
20191108150347 |
Precision medicine is a revolutionary approach for disease prevention and treatment that takes into account individual differences in lifestyle, environment, and biology. The All of Us Research Program seeks to extend precision medicine to all diseases by building a national research group of one million or more U.S. participants reflecting the rich diversity of the United States. Participants will have access to their results and will work as partners in the research process by maintaining involvement over time and receiving all of their study results. preventive medicine;disease prevention 2017-05 Christina Jordan, PhD cdjordan Preventive Medicine |
||||||||||||
AtRial Cardiopathy and Antithrombotic Drugs In prevention After crytogenic stroke Cognition and Silent Infarcts (Cognition and Silent Infarcts)IRB Number: 2019-0280
Published: January 27, 2020
View Locations
Clinical Trial Locations:
|
20200127131950 |
This is an ancillary study to the ARCADIA trial. It will assess cognitive function and silent infarcts in a subset of the ARCADIA population. Patients randomized in ARCADIA will be eligible for ARCADIA-CSI if they can undergo cognitive testing and have no MRI contraindications.The purpose of the study is to determine the effect of apixaban vs. aspirin on these two additional outcomes in patients with stroke of unknown cause and atrial cardiopathy. stroke 2019-0280 LaTronseya Berry sshekhar Stroke/Traumatic Brain Injury |
||||||||||||
Biobank MississippiIRB Number: 2016-0333
Published: September 14, 2023
View Locations
Clinical Trial Locations:
|
20230914081138 |
This proposal defines the plans for creation of a new resource for future research that will be available to all investigators at University of Mississippi Medical Center (UMMC) and Mayo Clinic (Mayo) through this joint project. We propose to recruit and enroll 10,000 participants. Participants will provide a blood sample for DNA, cells, and serum/plasma, complete a health questionnaire, and allow access to historical and future medical record data. assessment;biospecimens;healthy volunteer BIOBANK MISSISSIPPI Gouri J Mahajan, PhD gmahajan Genetics |
||||||||||||
Performance evaluation of the AMIA Automated Peritoneal Dialysis (APD) Solution Generation System in patients using the AMIA APD CyclerIRB Number: 2019-0048
Published: January 23, 2020
View Locations
Clinical Trial Locations:
|
20200123152732 |
This research study is being done to determine if the AMIA Automated Peritoneal Dialysis (APD) Solution Generation System is safe and works to administer peritoneal dialysis to participants with end‐stage renal (kidney) disease. The Consents have been amended to conform with protocol changes. kidney disease;kidney conditions BXU011787 Sherrin Dixon dmonga Kidney/Renal Conditions |
||||||||||||
Prospective comparison of ARNI with ARB Given following stabiLization In DEcompensated HFpEF (PARAGLIDE-HF)IRB Number: 2020-2778
Published: January 12, 2022
View Locations
Clinical Trial Locations:
|
20220112135215 |
The purpose of this research study is to find out if the study drug, sacubitril/valsartan, is safe and has beneficial effects when added to conventional heart failure therapy in patients with heart failure with preserved ejection fraction who have been stabilized after being admitted to the hospital for new or worsening heart failure. CLCZ696DUS01 Theresa Hutson rlong Heart Health |